Elutia (ELUT) to Release Quarterly Earnings on Thursday

Elutia (NASDAQ:ELUT) will issue its quarterly earnings data after the market closes on Thursday, November 14th. Parties that wish to register for the company’s conference call can do so using this link.

Elutia Price Performance

Elutia stock opened at $3.80 on Wednesday. The company has a fifty day simple moving average of $3.76 and a 200-day simple moving average of $3.67. The firm has a market capitalization of $129.43 million, a price-to-earnings ratio of -1.33 and a beta of 0.76. Elutia has a 52-week low of $1.39 and a 52-week high of $5.24.

Wall Street Analysts Forecast Growth

Separately, Cantor Fitzgerald restated an “overweight” rating and set a $10.00 price target on shares of Elutia in a research report on Friday, September 6th.

About Elutia

Elutia Inc, a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators.